Well Lead(SH:603309) Xin Lang Cai Jing·2025-10-21 01:51Core Points - Vili Medical's stock increased by 5.04% to 14.17 CNY per share, with a trading volume of 51.81 million CNY and a turnover rate of 1.27%, resulting in a total market capitalization of 4.15 billion CNY [1] - The company, established on April 30, 2004, and listed on March 2, 2015, specializes in the research, production, and sales of medical devices in various fields including anesthesia, urology, catheterization, nursing, respiratory care, and dialysis [1] - The revenue composition of Vili Medical is as follows: anesthesia 31.62%, catheterization 29.03%, urology 14.32%, nursing 11.45%, respiratory care 5.56%, dialysis 5.01%, and others 3.01% [1] Fund Holdings - The Xinda Australia Fund has a significant holding in Vili Medical, with the Xinda Small and Medium Cap Mixed A Fund (610004) reducing its stake by 69.96 thousand shares in the second quarter, now holding 77.05 thousand shares, which represents 4.54% of the fund's net value [2] - The fund has achieved a floating profit of approximately 523.9 thousand CNY as of the latest report [2] - The Xinda Small and Medium Cap Mixed A Fund was established on December 1, 2009, with a current size of 216 million CNY, and has recorded a year-to-date return of 24.01% [2] Fund Management - The fund is managed by Zeng Guofu and Li Diandian, with Zeng having a tenure of 17 years and 88 days, overseeing assets totaling 481 million CNY, achieving a best return of 109.1% during his tenure [3] - Li Diandian has been managing the fund for 1 year and 7 days, with assets of 570 million CNY, and has achieved a best return of 35.83% during his management period [3]